Vitamin B6 modulates CD8+ T cell antitumor responses
Developmental Cell · 2026-03 · 61 (3) · 468-469
DOI: 10.1016/j.devcel.2026.02.015 ↗Kurz gefasst
Kommentar in der Zeitschrift Developmental Cell, 2026-03. Verfasst von Iosifina P Foskolou. Beteiligte Einrichtung: Sanquin Blood Supply Foundation, Department of Research, 1066 CX Amsterdam, the Netherlands; Landsteiner Laboratory, Amsterdam UMC, University of Ams…. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Vitamin B 6, Neoplasms, Pyridoxal Phosphate. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
In this issue of Developmental Cell, Wu et al. report that the active form of vitamin B6, pyridoxal phosphate (PLP), enhances CD8+ T cell-dependent tumor clearance. Mechanistically, PLP maintains CD8+ T cells in a stemness-like state by inhibiting the nuclear translocation of BACH2. Here, we discuss these findings and their implications for cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Sanquin Blood Supply Foundation, Department of Research, 1066 CX Amsterdam, the Netherlands; Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands. Electronic address: i.fosk…
Zitieren
APA
Foskolou, I. P. (2026). Vitamin B6 modulates CD8+ T cell antitumor responses. Developmental Cell, 61(3), 468-469. https://doi.org/10.1016/j.devcel.2026.02.015
Vancouver
Foskolou IP. Vitamin B6 modulates CD8+ T cell antitumor responses. Developmental Cell. 2026;61(3):468-469. doi:10.1016/j.devcel.2026.02.015
BibTeX
@article{Foskolou2026,
author = {Foskolou, Iosifina P},
title = {Vitamin B6 modulates CD8+ T cell antitumor responses},
journal = {Developmental Cell},
year = {2026},
volume = {61},
number = {3},
pages = {468--469},
doi = {10.1016/j.devcel.2026.02.015}
}
EUVIMED